The U.S. is seeing an uptick in the use of mechanical resuscitation devices despite a paucity of evidence that the digitized CPR tools are effective, researchers reported in JAMA Network Open this fall.

The 2010s saw a decrease in age-adjusted mortality associated with heart disease, according to a JAMA Cardiology report, but a concomitant rise in heart failure-related deaths and increase in the global population of adults over 65 actually resulted in an increase in the number of fatalities attributed to CVD.

Multiarterial CABG was linked to lower rates of long-term mortality, reintervention and MI than single-arterial CABG in a recent study of heart patients, suggesting the multiarterial approach is underused in contemporary practice.

Research published in JACC: Heart Failure Nov. 6 uncovered a worrying statistic in cardiology: Older patients who are hospitalized for heart failure could experience as much as a 12% increase in the number of HF-exacerbating medications they’re prescribed between admission and hospital discharge.

Living with chronic stress could have serious implications for blood pressure control in black patients, Reuters reported Nov. 5.

A study out of the University of Pennsylvania School of Nursing suggests that weight loss achieved through a combination of intensive behavioral therapy and 3 milligrams of liraglutide daily results in optimal weight-related quality of life for patients struggling with obesity.

Edwards Lifesciences announced Nov. 6 that it had received expanded CE mark approval in Europe for the use of its SAPIEN 3 transcatheter heart valve, a tool designed to facilitate TAVI in patients who don’t want to undergo open-heart surgery.

A novel risk calculator developed by researchers at the Cleveland Clinic encourages patients with both type 2 diabetes and obesity to weigh their treatment options for optimal long-term health.